Review ArticleInternational Journal of Pharmaceutical InvestigationVol. 16 | Issue 1 | 2026 | pp. 51–57Open access
Digital Surveillance and Artificial Intelligence in Detection of AEFI: A New Frontier in Vaccine Safety Monitoring
- 1,
- 1*,
- 2
- 1 Department of Pharmacy Practice, JSS College of Pharmacy, JSS AHER, Mysuru, Karnataka, INDIA.
- 2 Department of Paediatrics, JSS Medical College, JSS AHER, Mysuru, Karnataka, INDIA.
Published in International Journal of Pharmaceutical Investigation
Correspondence: Madhan Ramesh
Department of Pharmacy Practice, JSS College of Pharmacy, JSS AHER, Mysuru, Karnataka, INDIA.
Email: mramesh@jssuni.edu.in
Copyright: © 2026 Manuscript Technomedia. This is an open access article.
- Published:
- Jan 1, 2026
- Received:
- May 26, 2025
- Accepted:
- Sep 12, 2025
- DOI:
- 10.5530/ijpi.20260414
How to cite
Siddiqui, S., Ramesh, M., & Narayana, P. S. (2026). Digital Surveillance and Artificial Intelligence in Detection of AEFI: A New Frontier in Vaccine Safety Monitoring. International Journal of Pharmaceutical Investigation, 16(1), 51–57. https://doi.org/10.5530/ijpi.20260414
Abstract
The integration of digital surveillance and Artificial Intelligence (AI) technology constitutes a significant shift in Adverse Event Following Immunization (AEFI) monitoring. This review explores the artificial intelligence based approaches such as machine learning, Natural Language Processing (NLP), and blockchain technology to improve vaccination safety surveillance. Artificial intelligence provides the immediate and accurate identification of safety signals by using a variety of data sources, such as electronic health records, social media platforms, and mobile health applications. Social media analytics have shown great promise for early detection of AEFIs, but blockchain protects the integrity and transparency of safety data. Despite these advances, difficulties remain, including underreporting, inequities in healthcare infrastructure, and ethical considerations including data privacy and biased algorithms. Low-resource environments, in specifically, experience challenges due to insufficient digital infrastructure and employee abilities. The assessment emphasizes the importance of combining old passive reporting systems with modern digital tools to develop a comprehensive and balanced AEFI monitoring framework. By addressing these barriers enabling global collaboration, digital technologies can increase the effectiveness of AEFI surveillance, increase confidence in vaccination programs, and improve emergency response times. This innovation in vaccine safety monitoring has the ability to address existing gaps and provide a strong framework for global immunization safety.
Keywords
Subject
Article metadata
| Title | Digital Surveillance and Artificial Intelligence in Detection of AEFI: A New Frontier in Vaccine Safety Monitoring |
|---|---|
| Authors | Soiba Siddiqui; Madhan Ramesh; Prashanth Sathya Narayana |
| Affiliations | Department of Pharmacy Practice, JSS College of Pharmacy, JSS AHER, Mysuru, Karnataka, INDIA.; Department of Paediatrics, JSS Medical College, JSS AHER, Mysuru, Karnataka, INDIA. |
| Corresponding author | mramesh@jssuni.edu.in |
| Journal | International Journal of Pharmaceutical Investigation |
| Volume / Issue | Vol. 16, Issue 1 (2026) |
Also in this issue
- Anti-Parkinson Drug Levodopa: It's Novel Delivery Systems, Preclinical and Clinical Studies: A Reviewpp. 1–11
- Shifting Regulatory Frameworks for Nanomedicine in the Evolution of Personalized Medicinepp. 12–22
- A Global Perspective on Navigating the Regulatory Landscape of Adaptive AI in Healthcare: Balancing Innovation and Patient Safetypp. 23–29
- Impact of Artificial Intelligence Assisted Drug Therapy Optimization on Drug Related Problems Amongst Older Adult Patients: A Systematic Reviewpp. 30–42
- The Empowerment of Drugs Inspectors Under the Drugs and Cosmetics Act, 1940-A Review of Implementation of Power of Arrest Conferred by Hon’ble Supreme Court of Indiapp. 43–50